Described are novel N- and C-terminally double truncated tau molecules, ("type IA, IB, IIA and IIB tau molecules") as well as methods for providing these molecules, both from recombinant and biological sources. Moreover, screening methods using these molecules in connection with Alzheimer's diagnosis and therapy are provided.

 
Web www.patentalert.com

< Novel fluorescent protein from aequorea coerulscens and methods for using the same

< Mutations of voltage-gated ion channnels that allow them to express a voltage-independent phenotype and an improved method to use the same

> Sequences from an endosymbiont and their uses

> Derivatives of monosaccharides for drug discovery

~ 00277